CT
MRNA icon

Colonial Trust’s Moderna MRNA Stock Holding History

Colonial Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-312
Closed -$8.61K – 1117
2025
Q2 		$8.61K Sell
312
-28
-8% -$737 ﹤0.01% 770
2025
Q1 		$9.64K Buy
340
+25
+8% +$887 ﹤0.01% 756
2024
Q4 		$13.1K Buy
315
+9
+3% +$430 ﹤0.01% 900
2024
Q3 		$20.4K Buy
306
+6
+2% +$551 ﹤0.01% 707
2024
Q2 		$35.6K Hold
300
– – 0.01% 566
2024
Q1 		$32K Sell
300
-2
-0.7% -$202 0.01% 581
2023
Q4 		$30K Sell
302
-33
-10% -$2.78K 0.01% 575
2023
Q3 		$34.6K Buy
335
+35
+12% +$3.9K 0.01% 540
2023
Q2 		$36.5K Hold
300
– – 0.01% 523
2023
Q1 		$46.1K Hold
300
– – 0.01% 474
2022
Q4 		$53.9K Buy
+300
New +$49.1K 0.01% 429

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Colonial Trust's MRNA Position: Q3 2025 in Review

Colonial Trust sold out of Moderna (MRNA) in Q3 2025, closing a stake of 312 shares — an estimated $8.61K sold.

Colonial Trust first reported a position in MRNA in Q4 2022 and held it in 11 quarters. The position peaked at $53.9K in Q4 2022. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Colonial Trust reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Colonial Trust sold 312 Moderna shares in Q3 2025, an estimated $8.61K.
  • Colonial Trust first reported a position in Moderna in Q4 2022 and held it in 11 quarters.
  • Colonial Trust's Moderna position peaked at $53.9K in Q4 2022.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Colonial Trust's 13F filing for Q3 2025, filed 10 Nov 2025.